🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › New York › Buffalo

Etid klinik pou Kansè renn (Kasinom selil renn) nan Buffalo, NY

6 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Buffalo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Ap rekriteFaz 1/2
  • Roswell Park Comprehensive, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05287945

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • Roswell Park Cancer Institute, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

Ap rekrite
  • Roswell Park Comprehensive Cancer Center, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07714018

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

Ap rekriteFaz 1/2
  • UB/ Great Lakes Cancer Care, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Apr 1, 2026 · NCT06222593

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • Roswell Park Cancer Institute, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Ap rekriteFaz 1/2
  • Roswell Park Cancer Institute, Buffalo
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT04787042

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Buffalo

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.